—    the F. D. A. has sometimes subordinated and neglected its other key obligation, which is to guide new medical innovations to market," Dr. Gottlieb wrote in 2012 in National Affairs, a   political journal. Some of Dr. Gottlieb’s views have alarmed researchers who argue that rigorous study of drugs and medical devices is the best way to ensure they work. In 2014, Dr. Gottlieb criticized a medical device study that used "sham," or dummy, procedures as a kind of placebo. 